AICURA medical GmbH

We’re excited to announce our participation in the upcoming 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗧𝗿𝗶𝗮𝗹𝘀 𝗼𝗻 𝗔𝗹𝘇𝗵𝗲𝗶𝗺𝗲𝗿'𝘀 𝗗𝗶𝘀𝗲𝗮𝘀𝗲 (𝗖𝗧𝗔𝗗) 𝗰𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲, taking place in 𝗠𝗮𝗱𝗿𝗶𝗱 𝗳𝗿𝗼𝗺 𝗢𝗰𝘁𝗼𝗯𝗲𝗿 𝟮𝟵 𝘁𝗼 𝗡𝗼𝘃𝗲𝗺𝗯𝗲𝗿 𝟭, 𝟮𝟬𝟮𝟰! Our CTO, Konstantin Thierbach, will present groundbreaking research on 𝗧𝗲𝗹𝗗𝗲𝗺 – our 𝗰𝘂𝘁𝘁𝗶𝗻𝗴-𝗲𝗱𝗴𝗲 𝗺𝘂𝗹𝘁𝗶𝗺𝗼𝗱𝗮𝗹 𝗔𝗜 𝗦𝘆𝘀𝘁𝗲𝗺 for the differential diagnosis of Alzheimer’s Disease (AD) and frontotemporal dementia (FTD) subtypes. This research is being conducted in a value-based partnership with 𝗣𝗿𝗼𝗳. 𝗠𝗮𝘁𝘁𝗵𝗶𝗮𝘀 𝗦𝗰𝗵𝗿𝗼𝗲𝘁𝗲𝗿 from the Max Planck Institute for Human Cognitive and Brain Sciences (MPI CBS). Together, we are pushing the boundaries of AI-driven diagnostics in neurodegenerative diseases. 𝗞𝗲𝘆 𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀 𝗼𝗳 𝗧𝗲𝗹𝗗𝗲𝗺: ➡️ >10% improvement in diagnostic accuracy over traditional methods. ➡️ Superior multiclass discrimination between dementia subtypes. ➡️ Enhanced interpretability, providing crucial insights into clinical biomarkers. TelDem integrates cognitive assessments, MRI scans, and demographic data to deliver more accurate diagnoses and support clinical workflows. 𝗧𝗲𝗹𝗗𝗲𝗺 𝗳𝗹𝗲𝘅𝗶𝗯𝗹𝗲 𝗮𝗿𝗰𝗵𝗶𝘁𝗲𝗰𝘁𝘂𝗿𝗲 𝗰𝗮𝗻 𝗮𝗹𝘀𝗼 𝗼𝗽𝘁𝗶𝗺𝗶𝘇𝗲 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘁𝗿𝗶𝗮𝗹𝘀, 𝗽𝗮𝘁𝗶𝗲𝗻𝘁 𝘀𝘁𝗿𝗮𝘁𝗶𝗳𝗶𝗰𝗮𝘁𝗶𝗼𝗻, 𝗮𝗻𝗱 𝗱𝗿𝘂𝗴 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁. 👉 If you're attending CTAD, 𝗷𝗼𝗶𝗻 𝘂𝘀 𝗮𝘁 𝗣𝗼𝘀𝘁𝗲𝗿 𝗟𝗣𝟭𝟬𝟲 (Theme 13: Digital Health/E-Trials) to explore AICURA´s impact in revolutionizing neurodegenerative disease research. We look forward to connecting and exploring collaboration opportunities! 💡 Can’t make it to Madrid? 𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗮𝗻 𝗶𝗻𝘁𝗿𝗼 𝘁𝗼𝗱𝗮𝘆 and discover how AICURA Medical can enhance your clinical trials. Please reach out to us: info@aicura-medical.com or directly 𝘀𝗰𝗵𝗲𝗱𝘂𝗹𝗲 𝗮 𝗱𝗲𝗺𝗼 https://lnkd.in/df7NVwcR #AIinHealthcare #CTAD2024 #AlzheimersResearch #DigitalHealth #ClinicalTrials #Neurodegeneration #AI 

We are looking for a BizDev and Sales manager! Are you interested in working at the intersection of healthcare, data, and AI? Then this job post is for you! https://lnkd.in/eQ-GXdih

We are looking for an experienced R&D manager! Are you interested in working at the intersection of medicine, data science, and software development? Then this job post is for you! https://lnkd.in/ekH8Ekbj

🌟 Exciting News! AICURA has been chosen to present at the 36th Global Conference of Alzheimer's Disease International (ADI) in Krakow from April 24-26, 2024.       ADI, in close partnership with the World Health Organization, is dedicated to improving Alzheimer's and dementia care worldwide.      Our presentation will feature TelDem, a groundbreaking project developed in collaboration with Matthias Schroeter from the Max Planck Institute for Human Cognitive and Brain Sciences. TelDem utilizes deep learning to classify and predict dementia syndromes, aiming to improve diagnosis.     🧠💪 Join us as we share our progress towards better patient outcomes in the fight against dementia.     Read more here: https://lnkd.in/egEBsAd6 #ADIConference #DementiaInnovations #AICURAResearch 

We are proud to announce that we are part of #sphinx! As our CEO, Daniel Lichterfeld stated (English translation below): "Sphin-X wird die Nutzung medizinischer Daten für die Entwicklung innovativer KI-Lösungen in der klinischen Forschung ermöglichen. Die Nutzung hochwertiger, medizinischer Daten aus dem deutschen Gesundheitssystem für die Beschleunigung und Optimierung von klinischen Studien bietet enormes Potenzial, nicht nur die Gesundheitsversorgung zu verbessern, sondern auch Deutschland wieder als einen der führenden internationalen Forschungsstandorte zu etablieren. Wir freuen uns darauf im Rahmen von sphin-X gemeinsam diese innovative Transformation des Gesundheitswesen voran zu treiben." "Sphin-X will enable the use of medical data for the development of innovative AI solutions in clinical research. The use of high-quality medical data from the German healthcare system to accelerate and optimise clinical trials offers enormous potential not only to improve healthcare, but also to re-establish Germany as one of the leading international research locations. We look forward to driving this innovative transformation of the healthcare system forward together as part of sphin-X."

✨ We're excited and humbled to announce that AICURA medical has been chosen as one of the Hello Tomorrow Deep-Tech Pioneers! 🤝 Come and meet us at the Hello Tomorrow Global Summit 2024, March 21-22nd in Paris. A global event dedicated to celebrating and accelerating deep-tech innovation. We are looking forward to networking with other fellow deep-tech visionaries. 👉 https://lnkd.in/gqHKN8vX #deeptechstartups #deeptech #globalsummit #aiinhealthcare  

✨ We're excited and humbled to announce that AICURA medical has been chosen as one of the Hello Tomorrow Deep-Tech Pioneers! 🤝 Come and meet us at the Hello Tomorrow Global Summit 2024, March 21-22nd in Paris. A global event dedicated to celebrating and accelerating deep-tech innovation. We are looking forward to networking with other fellow deep-tech visionaries. 👉 https://lnkd.in/gqHKN8vX #deeptechstartups #deeptech #globalsummit #aiinhealthcare  

🏆 Thrilled to announce the 3 finalists in 10 categories for the Tech Awards Gala 2023 by WLOUNGE 🌟 Our congratulations to the outstanding startups who made it to the finals––your brilliance is truly honorable. To those who gave their all but didn't make it this time, keep pushing boundaries. Your journey doesn't end here. Looking forward to celebrate the future of tech excellence at the Rotes Rathaus 🏆🌐 Don't hesitate to share your success dotLumen - Empowering the Blind Reverion COCOLI Divizend Brite Payments CREX Capital Edurino | We are hiring! Readmio Dream Kid AI atopia Torpor Games ZAUBAR German Bionic Mentessa - Learning as a culture MINTD GROPYUS VOLTARO syte UniWearables Nia Health GmbH AICURA medical GmbH TimeTeller GmbH Endoron Medical Thermosphr theblood IQONIC.AI Hy2Care® BV. ROSI #WTA2023 #TechAwardsGala2023 #Innovation #TechExcellence #WLOUNGE 🚀

🧠 We're thrilled to announce our partnership with Prof. Matthias Schroeter from the Max Planck Institute for Human Cognitive and Brain Sciences. Together, we're tackling a pressing healthcare challenge: accurate dementia diagnosis.    The partnership aims to create a multimodal deep learning tool (TelDem tool) that classifies dementia disorders and predicts their progression. The tool uses neuroimaging data, cognitive scores, and biomarkers to aid in the diagnostic and treatment decisions of dementia disorders. Because of its versatility, the TelDem tool can be eventually deployed in various healthcare settings, from urban centers to rural clinics. Additionally, the tool can be adapted to help optimize patient screening and identify the right patient cohorts for dementia clinical trials.      Our partnership is already streamlining data access and curation, saving up to 70% of data engineering time. AICURA is also equipping researchers with advanced deep-learning models for precise predictions using complex medical datasets. Inspired by transformer models, TelDem integrates various data types seamlessly, even handling missing information without compromising accuracy—a game-changer in multimodal patient care.    🚀 For more details on this collaboration, please reach out to us: info@aicura-medical.com. Read the full article here: https://lnkd.in/esw5AaGw

🧠 We're thrilled to announce our partnership with Prof. Matthias Schroeter from the Max Planck Institute for Human Cognitive and Brain Sciences. Together, we're tackling a pressing healthcare challenge: accurate dementia diagnosis.    The partnership aims to create a multimodal deep learning tool (TelDem tool) that classifies dementia disorders and predicts their progression. The tool uses neuroimaging data, cognitive scores, and biomarkers to aid in the diagnostic and treatment decisions of dementia disorders. Because of its versatility, the TelDem tool can be eventually deployed in various healthcare settings, from urban centers to rural clinics. Additionally, the tool can be adapted to help optimize patient screening and identify the right patient cohorts for dementia clinical trials.      Our partnership is already streamlining data access and curation, saving up to 70% of data engineering time. AICURA is also equipping researchers with advanced deep-learning models for precise predictions using complex medical datasets. Inspired by transformer models, TelDem integrates various data types seamlessly, even handling missing information without compromising accuracy—a game-changer in multimodal patient care.    🚀 For more details on this collaboration, please reach out to us: info@aicura-medical.com. Read the full article here: https://lnkd.in/esw5AaGw